Friedemann Weber
Reverse genetics of SARS-related coronavirus using vaccinia virus-based recombination
van den Worm S, Thiel V, Snijder E, Siddell S, Chang G, Dijkman R, Kuri T, Züst R, Weber F, Zevenhoven J, Eriksson K, Davidson A. Reverse genetics of SARS-related coronavirus using vaccinia virus-based recombination. PloS one 2012; 7:e32857.
07.03.2012Reverse genetics of SARS-related coronavirus using vaccinia virus-based recombination
07.03.2012PloS one 2012; 7:e32857
van den Worm Sjoerd H E, Thiel Volker, Snijder Eric J, Siddell Stuart G, Chang Guohui, Dijkman Ronald, Kuri Thomas, Züst Roland, Weber Friedemann, Zevenhoven Jessika C, Eriksson Klara Kristin, Davidson Andrew D
The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors
Pfefferle S, Hilgenfeld R, Schwarz F, Zimmer R, Steffen I, Weber F, Thiel V, Herrler G, Thiel H, Schwegmann-Weßels C, Pöhlmann S, Haas J, Drosten C, Pumpor K, Züst R, Schöpf J, Kögl M, Friedel C, Müller M, Carbajo-Lozoya J, Stellberger T, von Dall'armi E, Herzog P, Kallies S, Niemeyer D, Ditt V, Kuri T, von Brunn A. The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors. PLoS Pathog 2011; 7:e1002331.
27.10.2011The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors
27.10.2011PLoS Pathog 2011; 7:e1002331
Pfefferle Susanne, Hilgenfeld Rolf, Schwarz Frank, Zimmer Ralf, Steffen Imke, Weber Friedemann, Thiel Volker, Herrler Georg, Thiel Heinz-Jürgen, Schwegmann-Weßels Christel, Pöhlmann Stefan, Haas Jürgen, Drosten Christian, Pumpor Ksenia, Züst Roland, Schöpf Julia, Kögl Manfred, Friedel Caroline C, Müller Marcel A, Carbajo-Lozoya Javier, Stellberger Thorsten, von Dall'armi Ekatarina, Herzog Petra, Kallies Stefan, Niemeyer Daniela, Ditt Vanessa, Kuri Thomas, von Brunn Albrecht
The ADP-ribose-1''-monophosphatase domains of severe acute respiratory syndrome coronavirus and human coronavirus 229E mediate resistance to antiviral interferon responses
Kuri T, Ziebuhr J, Thiel V, Siddell S, Davidson A, Snijder E, Züst R, Putics A, Eriksson K, Weber F. The ADP-ribose-1''-monophosphatase domains of severe acute respiratory syndrome coronavirus and human coronavirus 229E mediate resistance to antiviral interferon responses. J Gen Virol 2011; 92:1899-905.
27.04.2011The ADP-ribose-1''-monophosphatase domains of severe acute respiratory syndrome coronavirus and human coronavirus 229E mediate resistance to antiviral interferon responses
27.04.2011J Gen Virol 2011; 92:1899-905
Kuri Thomas, Ziebuhr John, Thiel Volker, Siddell Stuart G, Davidson Andrew D, Snijder Eric J, Züst Roland, Putics Akos, Eriksson Klara K, Weber Friedemann
Virus-like particles expressing the nucleocapsid gene as an efficient vaccine against Rift Valley fever virus
Pichlmair A, Habjan M, Unger H, Weber F. Virus-like particles expressing the nucleocapsid gene as an efficient vaccine against Rift Valley fever virus. Vector Borne Zoonotic Dis 2010; 10:701-3.
01.10.2010Virus-like particles expressing the nucleocapsid gene as an efficient vaccine against Rift Valley fever virus
01.10.2010Vector Borne Zoonotic Dis 2010; 10:701-3
Pichlmair Andreas, Habjan Matthias, Unger Hermann, Weber Friedemann
Toscana virus induces interferon although its NSs protein reveals antagonistic activity
Gori Savellini G, Weber F, Terrosi C, Habjan M, Martorelli B, Cusi M. Toscana virus induces interferon although its NSs protein reveals antagonistic activity. J Gen Virol 2010; 92:71-9.
22.09.2010Toscana virus induces interferon although its NSs protein reveals antagonistic activity
22.09.2010J Gen Virol 2010; 92:71-9
Gori Savellini Gianni, Weber Friedemann, Terrosi Chiara, Habjan Matthias, Martorelli Barbara, Cusi Maria Grazia
Species-independent bioassay for sensitive quantification of antiviral type I interferons
Kuri T, Habjan M, Penski N, Weber F. Species-independent bioassay for sensitive quantification of antiviral type I interferons. Virol J 2010; 7:50.
01.01.2010Species-independent bioassay for sensitive quantification of antiviral type I interferons
01.01.2010Virol J 2010; 7:50
Kuri Thomas, Habjan Matthias, Penski Nicola, Weber Friedemann
Interferon priming enables cells to partially overturn the SARS coronavirus-induced block in innate immune activation
Kuri T, Zhang X, Habjan M, Martínez-Sobrido L, García-Sastre A, Yuan Z, Weber F. Interferon priming enables cells to partially overturn the SARS coronavirus-induced block in innate immune activation. J Gen Virol 2009; 90:2686-94.
01.11.2009Interferon priming enables cells to partially overturn the SARS coronavirus-induced block in innate immune activation
01.11.2009J Gen Virol 2009; 90:2686-94
Kuri Thomas, Zhang Xiaonan, Habjan Matthias, Martínez-Sobrido Luis, García-Sastre Adolfo, Yuan Zhenghong, Weber Friedemann
NSs protein of rift valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinase
Habjan M, Pichlmair A, Elliott R, Overby A, Glatter T, Gstaiger M, Superti-Furga G, Unger H, Weber F. NSs protein of rift valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinase. J Virol 2009; 83:4365-75.
01.05.2009NSs protein of rift valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinase
01.05.2009J Virol 2009; 83:4365-75
Habjan Matthias, Pichlmair Andreas, Elliott Richard M, Overby Anna K, Glatter Timo, Gstaiger Matthias, Superti-Furga Giulio, Unger Hermann, Weber Friedemann
Vaccination with virus-like particles protects mice from lethal infection of Rift Valley Fever Virus
Näslund J, Lagerqvist N, Habjan M, Lundkvist A, Evander M, Ahlm C, Weber F, Bucht G. Vaccination with virus-like particles protects mice from lethal infection of Rift Valley Fever Virus. Virology 2009; 385:409-15.
15.03.2009Vaccination with virus-like particles protects mice from lethal infection of Rift Valley Fever Virus
15.03.2009Virology 2009; 385:409-15
Näslund Jonas, Lagerqvist Nina, Habjan Matthias, Lundkvist Ake, Evander Magnus, Ahlm Clas, Weber Friedemann, Bucht Göran
Efficient production of Rift Valley fever virus-like particles: The antiviral protein MxA can inhibit primary transcription of bunyaviruses
Habjan M, Penski N, Wagner V, Spiegel M, Overby A, Kochs G, Huiskonen J, Weber F. Efficient production of Rift Valley fever virus-like particles: The antiviral protein MxA can inhibit primary transcription of bunyaviruses. Virology 2009; 385:400-8.
15.03.2009Efficient production of Rift Valley fever virus-like particles: The antiviral protein MxA can inhibit primary transcription of bunyaviruses
15.03.2009Virology 2009; 385:400-8
Habjan Matthias, Penski Nicola, Wagner Valentina, Spiegel Martin, Overby Anna K, Kochs Georg, Huiskonen Juha T, Weber Friedemann
T7 RNA polymerase-dependent and -independent systems for cDNA-based rescue of Rift Valley fever virus
Habjan M, Penski N, Spiegel M, Weber F. T7 RNA polymerase-dependent and -independent systems for cDNA-based rescue of Rift Valley fever virus. J Gen Virol 2008; 89:2157-66.
01.09.2008T7 RNA polymerase-dependent and -independent systems for cDNA-based rescue of Rift Valley fever virus
01.09.2008J Gen Virol 2008; 89:2157-66
Habjan Matthias, Penski Nicola, Spiegel Martin, Weber Friedemann
Interferon and cytokine responses to SARS-coronavirus infection
Thiel V, Weber F. Interferon and cytokine responses to SARS-coronavirus infection. Cytokine & growth factor reviews 2008; 19:121-32.
01.04.2008Interferon and cytokine responses to SARS-coronavirus infection
01.04.2008Cytokine & growth factor reviews 2008; 19:121-32
Thiel Volker, Weber Friedemann
Processing of genome 5' termini as a strategy of negative-strand RNA viruses to avoid RIG-I-dependent interferon induction
Habjan M, Mirazimi A, Mühlberger E, Schneider U, Pichlmair A, Wagner V, Zimmermann P, Martin A, Schümann M, Klingström J, Andersson I, Weber F. Processing of genome 5' termini as a strategy of negative-strand RNA viruses to avoid RIG-I-dependent interferon induction. PloS one 2008; 3:e2032.
01.01.2008Processing of genome 5' termini as a strategy of negative-strand RNA viruses to avoid RIG-I-dependent interferon induction
01.01.2008PloS one 2008; 3:e2032
Habjan Matthias, Mirazimi Ali, Mühlberger Elke, Schneider Urs, Pichlmair Andreas, Wagner Valentina, Zimmermann Petra, Martin Arnold, Schümann Michael, Klingström Jonas, Andersson Ida, Weber Friedemann
Coronavirus non-structural protein 1 is a major pathogenicity factor: implications for the rational design of coronavirus vaccines
Züst R, Cervantes-Barragan L, Kuri T, Blakqori G, Weber F, Ludewig B, Thiel V. Coronavirus non-structural protein 1 is a major pathogenicity factor: implications for the rational design of coronavirus vaccines. PLoS pathogens 2007; 10;3(8):e109:1062-1072.
01.08.2007Coronavirus non-structural protein 1 is a major pathogenicity factor: implications for the rational design of coronavirus vaccines
01.08.2007PLoS pathogens 2007; 10;3(8):e109:1062-1072
Züst Roland, Cervantes-Barragan Luisa, Kuri Thomas, Blakqori Gjon, Weber Friedemann, Ludewig Burkhard, Thiel Volker
La Crosse bunyavirus nonstructural protein NSs serves to suppress the type I interferon system of mammalian hosts
Blakqori G, Staeheli P, Michiels T, Weiss S, Kalinke U, Kohl A, Fragkoudis R, Attarzadeh-Yazdi G, Olson K, Sánchez-Vargas I, Blair C, Habjan M, Delhaye S, Weber F. La Crosse bunyavirus nonstructural protein NSs serves to suppress the type I interferon system of mammalian hosts. J Virol 2007; 81:4991-9.
01.05.2007La Crosse bunyavirus nonstructural protein NSs serves to suppress the type I interferon system of mammalian hosts
01.05.2007J Virol 2007; 81:4991-9
Blakqori Gjon, Staeheli Peter, Michiels Thomas, Weiss Siegfried, Kalinke Ulrich, Kohl Alain, Fragkoudis Rennos, Attarzadeh-Yazdi Ghassem, Olson Ken E, Sánchez-Vargas Irma, Blair Carol D, Habjan Matthias, Delhaye Sophie, Weber Friedemann
Control of coronavirus infection through plasmacytoid dendritic-cell-derived type I interferon
Cervantes-Barragan L, Züst R, Weber F, Spiegel M, Lang K, Akira S, Thiel V, Ludewig B. Control of coronavirus infection through plasmacytoid dendritic-cell-derived type I interferon. Blood 2007; 109:1131-7.
01.02.2007Control of coronavirus infection through plasmacytoid dendritic-cell-derived type I interferon
01.02.2007Blood 2007; 109:1131-7
Cervantes-Barragan Luisa, Züst Roland, Weber Friedemann, Spiegel Martin, Lang Karl S, Akira Shizuo, Thiel Volker, Ludewig Burkhard